Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer

NCT07042256 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT07042256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07042256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer
Lead sponsor
University of Zurich
Phase
Not applicable
Overall status
Recruiting
Start date
June 9, 2026
Completion date
September 30, 2031
Enrollment
13 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized prostate adenocarcinoma